What VSY Biotechnology does

VSY Biotechnology GmbH is a German-headquartered, privately held medical device manufacturer founded in 2009 and based in Leinfelden-Echterdingen near Stuttgart, employing 251–500 staff. The company develops, manufactures and sells ophthalmology-focused products including intraocular lenses (IOLs) and supporting surgical devices, with additional revenue streams in orthobiologic viscosupplementation and hyaluronic-acid-based medical aesthetics.

Its core product architecture is built around two IOL platforms: the Enova Family of preloaded, 100% Glistening-Free hydrophobic IOLs (including Enova Maestro with Sinusoidal Vision Technology (SVT®), Enova Advanced® EDoF, and Enova Monofocal variants) and the AcrivaUD Family of pupil-adaptive hydrophobic surface IOLs (including Acriva Trinova, Trinova Pro, and toric versions). Supporting surgical products include the patented Rotaryjet™ Preloaded Delivery System, the Acrijetfly cartridge injector, and the Protectalon line of bio-fermented sodium hyaluronate viscoelastics offered in seven concentrations. Orthobiologic and aesthetic lines (Recross, Reviscon, Joy, Shine, Shape, Berry, Eyes) extend the hyaluronic acid manufacturing capability into adjacent verticals.

VSY operates a B2B enterprise model selling to ophthalmologists, eye surgeons, and clinics, primarily through a network of regional distributors accessed via the VSYOphthalmologyDistributorHub and direct enterprise sales. Pricing is quote-based with standard 30-day invoice terms. The company maintains MDSAP quality certification, holds patents in China (SVT®) and at the European Patent Institute (Rotaryjet™), and has entered Japan via a 2021 licensing partnership with Wakamoto Pharmaceutical. Annual ESCRS congress participation and the Ophthalmology Star Awards programme anchor its go-to-market with European and international ophthalmic surgeons.

Name

VSY Biotechnology

Legal name

VSY Biotechnology GmbH

Website

https://vsybiotechnology.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

VSY Biotechnology GmbH is a Germany-based medical device manufacturer developing premium intraocular lenses, viscoelastics, orthobiologics, and medical aesthetics for ophthalmologists, surgeons, and clinics globally.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

Keywords

• Ophthalmic medical devices
• Intraocular lenses
• Cataract surgery products
• Viscoelastic solutions
• Orthobiologic injections

Headquarters

HQ city

Leinfelden-echterdingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Intraocular Lens (IOL) Sales: Sale of premium intraocular lenses including the Enova and Acriva families. Products include monofocal, trifocal, extended depth of focus (EDoF), and toric models for cataract and refractive surgery.
2. Viscoelastic Products: Protectalon brand bio-fermented sodium hyaluronate products for smooth ophthalmic surgeries. Available in 7 different concentrations.
3. Cartridge Injector Systems: Sale of Rotaryjet preloaded delivery systems and Acrijet cartridge injector systems for IOL delivery.
4. Orthobiologics: Recross and Reviscon hyaluronic acid products for orthopedic applications providing long-lasting pain relief through IA-HA solutions.
5. Medical Aesthetics: Hyaluronic acid-based aesthetic products (Joy, Shine, Shape, Berry, Eyes) for medical aesthetics applications.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

VSY Biotechnology GmbH develops, designs, and manufactures medical devices and biotechnology products primarily for ophthalmology, with additional offerings in orthobiologics and medical aesthetics. The company sells intraocular lenses (IOLs), viscoelastic solutions, preloaded and cartridge injector delivery systems, and hyaluronic acid-based orthobiologic and aesthetic products to healthcare professionals, clinics, and distributor partners worldwide.

Product overview

VSY Biotechnology GmbH offers a diversified portfolio of medical devices and biotechnology products spanning ophthalmology, aesthetics, and orthobiologics. The core ophthalmology business centers on the Enova Family of preloaded 100% glistening-free hydrophobic IOLs (including Enova Maestro, Enova Advanced, and Enova Monofocal variants) and the AcrivaUD Family of hydrophobic surface IOLs. The company also provides supporting surgical products including the Rotaryjet Preloaded Delivery System, Acrijetfly cartridge injector, and Protectalon viscoelastics. In orthobiologics, VSY Biotechnology offers Recross and Reviscon hyaluronic acid-based solutions for pain management. The product architecture is organized as distinct platform families with specialized variants (toric, presbyopia-correcting) and complementary delivery/injection systems.

Differentiator

Problem solved

Functional benefit

Brands

• Enova Family: Preloaded 100% Glistening-Free Hydrophobic IOL Platform featuring products like Enova Maestro (presbyopia), Enova Advanced EDoF IOL, and Enova Monofocal
• AcrivaUD Family
• Protectalon
• Rotaryjet
• Sinusoidal Vision Technology (SVT®)
• Golden Ratio in IOL Technology™

Products and services

• Enova Maestro Presbyopia-correcting intraocular lens featuring Sinusoidal Vision Technology (SVT) for enhanced visual outcomes after cataract surgery, targeting ophthalmologists and cataract surgeons.
• Enova Advanced Extended Depth of Focus (EDoF) intraocular lens with Light Tailoring Technology for next-generation vision correction after cataract surgery.
• Enova Monofocal Standard monofocal intraocular lens for cataract surgery, available in standalone and toric variants, made from 100% Glistening-Free hydrophobic material.
• Enova Maestro Toric Toric version of the Enova Maestro IOL with Sinusoidal Vision Technology for correction of astigmatism during cataract surgery.
• Enova Advanced Toric Toric version of the Enova Advanced EDoF IOL for cataract patients with astigmatism.
• Rotaryjet Preloaded Delivery System Patented preloaded injector system for delivery of hydrophobic intraocular lenses, featuring visual and audible feedback and a push-and-pull mechanism for safe insertion.
• Acriva Trinova Hydrophobic surface intraocular lens platform with pupil-adaptive technology for cataract surgery.
• Acriva Trinova Pro Enhanced version of Acriva Trinova with advanced pupil-adaptive technology, positioned as a presbyopia-correcting IOL with patented enhanced technology.
• Acriva Hydrophobic surface intraocular lens platform for cataract surgery.
• Acriva Toric Toric version of Acriva IOL for astigmatism correction during cataract surgery.
• Acrijetfly Cartridge Injector System Cartridge injector system with semi-translucent design, locking system, and Railguard design for optimized intraocular lens loading.
• Protectalon Viscoelastic product line made from bio-fermented sodium hyaluronate in 7 different concentrations, used for smooth and confident ophthalmic surgeries.
• Recross One-shot intra-articular hyaluronic acid (IA-HA) solution for long-lasting joint pain relief in orthopedic applications.
• Reviscon Linear sodium hyaluronate product in three concentrations (20mg 1.0%, 32mg 1.6%, 48mg 2.0%) for orthopedic viscosupplementation applications.

Quantifiable outcome

• 10%+ market share in German cataract surgeries with Protectalon
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• WAKAMOTO PHARMACEUTICAL CO., LTD.coreChannel Partner/ Reseller/ Distributor · 19 March 2021VSY Biotechnology signed an agreement with WAKAMOTO PHARMACEUTICAL for licensing arrangement to develop and launch intraocular lens products in Japan. This partnership represents VSY's entry into the Japanese medical device market, with WAKAMOTO leveraging their existing ophthalmology presence in Japan.
• Clarius Mobile Health Corp.minorStrategic or Co-development PartnerStrategic partnership with Clarius Mobile Health Corp. mentioned as a collaboration in the biotechnology and medical device sector, though specific details of the partnership scope are limited in available materials.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Alcon: World's largest ophthalmic medical device company and the global IOL market leader (PanOptix, Vivity families). Directly competes with VSY across monofocal, toric, EDoF, and presbyopia-correcting IOLs and has the broadest distribution and clinical-evidence infrastructure.
• Hoya Corporation (Vision Care): Through Hoya Surgical Optics, markets the Vivinex and iSert preloaded IOL systems globally, directly competing with VSY's Enova preloaded platform and Rotaryjet injector technology.
• Bausch + Lomb: Markets the enVista and LuxSmart IOL platforms and competes in the premium IOL segment with VSY, particularly in Europe. Also sells ophthalmic viscoelastic devices, overlapping directly with VSY's Protectalon line.
• Carl Zeiss Meditec: German-headquartered ophthalmic systems leader offering the CT LUCIA and CT SPHERIS IOL families alongside surgical microscopes and diagnostics. A directly comparable peer for VSY's premium IOL portfolio and a fellow DACH-based competitor.
• Johnson & Johnson Vision: Operates the TECNIS IOL platform (monofocal, multifocal, EDoF, toric, Symfony) and competes head-to-head with VSY's AcrivaUD and Enova families. Backed by J&J's global cataract surgery salesforce and surgeon education programs.

Direct peers

• HumanOptics: German-headquartered ophthalmic implant manufacturer offering IOLs and corneal implants. Directly comparable mid-sized European competitor in the cataract surgery device space and a fellow DACH-market rival.
• PhysIOL: Belgian premium IOL specialist (FineVision, Pod, Isopure families) competing directly in trifocal and EDoF IOLs — overlapping with VSY's Acriva Trinova and Enova Advanced product lines.
• Santen Pharmaceutical: Japan-headquartered ophthalmology specialist with a portfolio of intraocular lenses and surgical devices. Directly comparable peer for VSY's premium IOL franchise and an obvious potential partner or competitor in the Japanese market where VSY has partnered with Wakamoto.
• Teleon Surgical: Spun out of Oculentis and focused on premium IOLs (Lentis family) including multifocal and EDoF designs. Closely comparable in scale, premium-IOL focus, and European footprint — directly competes with VSY's AcrivaUD and Enova platforms.
• Lenstec: Privately held medical device company focused on intraocular lenses including the Tetraflex and SBL-3 platforms. Comparable mid-sized peer competing in premium cataract IOLs with a similar specialty-only positioning to VSY.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vsybiotech

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VSY Biotechnology